Published in December….
Rivaroxaban for Preventing Atherothrombotic Events in People with Acute Coronary Syndrome and Elevated Cardiac Biomarkers: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Pandor A, Pollard D, Chico T, Henderson R, Stevenson M
Pharmacoeconomics 21 Dec 2015
Eliciting Societal Preferences for Weighting QALYs for Burden of Illness and End of Life.
Rowen D, Brazier J, Mukuria C, Keetharuth A, Risa Hole A, Tsuchiya A, Whyte S, Shackley P
Med Decis Making 36(2):210-222 Feb 2016
Is there a role for telemedicine in cystic fibrosis? A systematic review.
Curley R, Hoo ZH, Archer R, Wildman MJ
Thorax. 70: A218-A219. Dec 2015
Improving Cross-Sector Comparisons: Going Beyond the Health-Related QALY
Brazier J, Tsuchiya A
Applied Health Economics and Health Policy 13(6):557-565 01 Dec 2015
EQ-5D in skin conditions: an assessment of validity and responsiveness
Yang Y, Brazier J, Longworth L
European Journal of Health Economics 16(9):927-939 01 Dec 2015
